Showing results (2231-2240 of 2,381) with videos related to
Sort By:
Pageof 239
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancerM L Rothenberg, J R Eckardt, J G Kuhn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignanciesM Hidalgo, M A Villalona-Calero, S G Eckhardt, et al.AJR. American Journal of Roentgenology|November 20, 2002
Gadobenate dimeglumine-enhanced MR angiography of the abdominal aorta and renal arteriesThomas J Kroencke, Martin N Wasser, Peter M T Pattynama, et al.Journal for Immunotherapy of Cancer|February 10, 2019
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenograftsA Capasso, J Lang, T M Pitts, et al.Frontiers in Pharmacology|April 2, 2013
Association of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer modelsTodd M Pitts, Gillian N Kulikowski, Aik-Choon Tan, et al.Wiener Klinische Wochenschrift|February 5, 2019
Diagnostic delay in patients with inflammatory bowel disease in AustriaGottfried Novacek, Hans Peter Gröchenig, Thomas Haas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2010
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumorsJennifer R Diamond, Bruno R Bastos, Ryan J Hansen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 1998
Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumorsM L Rothenberg, A Sharma, G R Weiss, et al.Cancer Discovery|September 14, 2018
Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein NetworkManon Eckhardt, Wei Zhang, Andrew M Gross, et al.Neuro-Oncology|March 3, 2023
Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entitiesCatena Kresbach, Matthias Dottermusch, Alicia Eckhardt, et al.Pageof 239